Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Jan 23, 2020 1:00am

92 Views

Post# 30586536

RE:Poland seem to be going lots of islet cell transplants by

edrose wrote: Doctors trained in Chicago,must be frustrating that fda doesn’t approve these transplants
so far they are getting excellent results in Poland but they are using different technique
with million of Americans with diabetes why can’t they find patients ( seven for this phase) to use pouch and transplant islets . And get data

EdRose are you for real? You should not be allowed to invest without an adult present. Fda has approved the implants for in the study. I think the next indication for the pouch will be a brain transplant. We have one candidate ready to go? Rosie can you guess who it is? Not selfie.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features